Pfizer

Pfizer says antibiotic is effective against tough-to-treat infections
Pfizer says antibiotic is effective against tough-to-treat infections
BioPharma Dive
Pfizer
antibiotics
clinical trials
drug-resistant infections
ATM-AVI
Flag link:
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
NICE gives thumbs-up to Pfizer's migraine drug—but with lots of restrictions
Fierce Pharma
Biohaven
Pfizer
migraines
NICE
Nurtec
Vydura
Flag link:
FDA approves Pfizer’s RSV vaccine for older adults
FDA approves Pfizer’s RSV vaccine for older adults
Stat
Pfizer
vaccines
FDA
elderly
RSV
Abrysvo
Flag link:
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence
Biopharma Reporter
obesity
weight loss
Novo Nordisk
Eli Lilly
Pfizer
Amgen
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit
Fierce Pharma
Alnylam Pharmaceuticals
legal
patents
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Flag link:
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Pfizer's hemophilia drug hits in phase 3, giving it a chance to leapfrog Novo Nordisk
Fierce Biotech
Pfizer
Novo Nordisk
clinical trials
hemophilia
marstacimab
Flag link:
Pfizer's Heading for a Patent Cliff
Pfizer's Heading for a Patent Cliff
Motley Fool
Pfizer
patents
patent cliff
Flag link:
Pfizer’s etrasimod aims to differentiate UC market with strong safety profile
Pfizer’s etrasimod aims to differentiate UC market with strong safety profile
Clinical Trials Arena
Pfizer
etrasimod
ulcerative colitis
Flag link:
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Science finally figured out how to make effective RSV vaccines. Will seniors care?
Stat
RSV
vaccines
elderly
Pfizer
GSK
Flag link:
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
CNBC
Pfizer
Paxlovid
COVID-19
FDA
antivirals
Flag link:
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
Motley Fool
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
Flag link:
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Pfizer Stock Jumps After Diabetes Drug Tops Ozempic In Weight Loss
Investors Business Daily
Pfizer
Novo Nordisk
weight loss
Ozempic
danuglipron
clinical trials
Flag link:
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Pfizer Just Took Out $31 Billion in Debt. Here's Why That's Good News
Motley Fool
Pfizer
debt
Seagen
M&A
Flag link:
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
CureVac’s COVID vaccine patent battle with Pfizer, BioNTech heads South
Medical Marketing and Media
CureVac
COVID-19
vaccines
Pfizer
BioNTech
patents legal
Flag link:
How I helped Pfizer think through the ethics of Viagra 25 years ago
How I helped Pfizer think through the ethics of Viagra 25 years ago
Stat
Pfizer
Viagra
ethics
erectile dysfunction
Flag link:
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns
Stat
Pfizer
RSV
vaccines
FDA
Flag link:
Pfizer product PR still up for grabs
Pfizer product PR still up for grabs
Medical Marketing and Media
Pfizer
public relations
Flag link:
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel
BioSpace
Pfizer
FDA
RSV
vaccines
Abrysvo
Flag link:
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Flag link:

Pages